MARKET

MYGN

MYGN

Myriad Genetics
NASDAQ
3.810
+0.260
+7.32%
After Hours: 3.836 +0.026 +0.69% 16:46 05/20 EDT
OPEN
3.550
PREV CLOSE
3.550
HIGH
3.820
LOW
3.535
VOLUME
2.10M
TURNOVER
--
52 WEEK HIGH
8.59
52 WEEK LOW
3.530
MARKET CAP
359.85M
P/E (TTM)
-0.8828
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MYGN last week (0511-0515)?
Weekly Report · 2d ago
Actress Jackie Tohn Got Results Nobody Wants But They May Have Saved Her Life
Barchart · 5d ago
Top Myriad Genetics Insider Makes Bold New Move on Company Stock
TipRanks · 5d ago
Myriad Genetics Director Paul Bisaro acquires 7,500 shares for $27,637.50
PUBT · 5d ago
Piper Sandler Sticks to Its Buy Rating for Myriad Genetics (MYGN)
TipRanks · 05/12 11:26
Weekly Report: what happened at MYGN last week (0504-0508)?
Weekly Report · 05/11 09:17
Tempus AI: My Pick For An Oncoming Boom In Demand For Data-Driven Precision Medicine
Seeking Alpha · 05/08 17:25
Myriad Genetics to join Goldman Sachs Global Healthcare Conference fireside chat
PUBT · 05/07 20:29
More
About MYGN
Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has specialized products, capabilities, and expertise: Oncology, Women's Health, and Mental Health. In oncology, it offers testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs and treatments. It also offers the SneakPeek Early Gender DNA Test, which can reveal a baby's gender as early as six weeks into pregnancy. The Company’s testing products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, Foresight, Prequel, Precis Tumor, Precise Liquid, SneakPeek and GeneSight, among others.

Webull offers Myriad Genetics Inc stock information, including NASDAQ: MYGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MYGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MYGN stock methods without spending real money on the virtual paper trading platform.